Lucinactant

Overview

Lucinactant (trade name Surfaxin) is a liquid medication used to treat Infant Respiratory Distress Syndrome in infants. A synthetic human lung surfactant consisting of peptide KL4, dipalmitoylphosphatidylcholine, palmitoyloleoylphosphatidylglycerol, and palmitic acid. Sequence: KLLLLKLLLLKLLLLKLLLLK

Application

Products > Drug Discovery > APIs > Generic APIs | Products > Drug Discovery > Inhibitor

Product Information

• Catalog No.: B0084-462251
• CAS No.: 825600-90-6
• Molecular Formula: C128H242N26O24
• Molecular Weight: 2529.5
• Purity: 98%

Source

Original product source